Landman, Roland <br/><br/>
Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study.  [electronic resource] 

 -  The Journal of antimicrobial chemotherapy  Jul 2009 
 - 118-25 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1460-2091 
<br/><br/><label>Standard No.: </label>10.1093/jac/dkp146  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-HIV Agents--adverse effects<br/>Antiretroviral Therapy, Highly Active--adverse effects<br/>Asparagine--adverse effects<br/>Atazanavir Sulfate<br/>CD4 Lymphocyte Count<br/>Carbamates--adverse effects<br/>Female<br/>Furans<br/>HIV Infections--drug therapy<br/>HIV Protease Inhibitors--adverse effects<br/>HIV-1--drug effects<br/>Humans<br/>Male<br/>Middle Aged<br/>Oligopeptides--adverse effects<br/>Organophosphates--adverse effects<br/>Pyridines--adverse effects<br/>Quinolines--adverse effects<br/>RNA, Viral--blood<br/>Ritonavir--adverse effects<br/>Sulfonamides--adverse effects<br/>Treatment Outcome<br/>Viral Load